INTERMUNE PHARMACEUTICALS INC
POS AM, EX-23.1, 2000-10-30
PHARMACEUTICAL PREPARATIONS
Previous: INTERMUNE PHARMACEUTICALS INC, POS AM, 2000-10-30
Next: INTERMUNE PHARMACEUTICALS INC, POS AM, EX-27.2, 2000-10-30



<PAGE>
                                                                    Exhibit 23.1

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

    We consent to the references to our firm under the captions "Selected
Financial Data" and "Experts" and to the use of our report dated January 28,
2000, except for the second and sixth paragraphs under "Stock Compensation
Plans" in note 6 to the financial statements and the third paragraph under
"Deferred Compensation" in note 6 to the financial statements as to which the
date is February 29, 2000, in the Registration Statement on Form S-1 and related
Prospectus of InterMune Pharmaceuticals, Inc. for the registration of 2,000,000
shares of its common stock.

                                                           /s/ ERNST & YOUNG LLP

Palo Alto, California
October 27, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission